ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00034463 |
|
Recruitment Status :
Completed
First Posted : April 30, 2002
Last Update Posted : July 19, 2006
|
Sponsor:
Eli Lilly and Company
Information provided by:
Eli Lilly and Company
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | No date given |